Concepedia

Author

Maddalena Barba

National Cancer InstituteORCID

Also Known As

Barba, M., L Caravatta, M Barba, M Frigerio, M Saez barba, M. Barba, Maddalena Barba, R Pujol Pina

218

Publications

6.8K

Citations

43

H-Index

75

Concepts

All Affiliations

National Cancer InstituteUniversity of Chieti-PescaraIstituti di Ricovero e Cura a Carattere ScientificoUniversità Cattolica del Sacro CuoreSapienza University of Rome
MB

About

Maddalena Barba is an author at National Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

24

833

2

Public Health

4

4

107

3

Health Sciences

3

3

76

4

Engineering

1

1

11

5

Social Sciences

1

1

16

Maddalena Barba

×

73

Publications

2.6K

Citations

29

H-Index

YearCitations

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa,

The Lancet Oncology

2021

280

KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden

Daniele Marinelli, Marco Mazzotta, Stefano Scalera,

Annals of Oncology

2020

218

Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients

Vincenzo Graziano, Antonino Grassadonia, Laura Iezzi,

The Breast

2019

170

KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy

Stefano Scalera, Marco Mazzotta, Giacomo Corleone,

Journal of Thoracic Oncology

2021

76

Erythrocyte Membrane Phospholipid Composition as a Biomarker of Dietary Fat

Barbara J. Fuhrman, Maddalena Barba, Vittorio Krogh,

Annals of Nutrition and Metabolism

2005

74

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

Giulia Bon, Laura Pizzuti, Valentina Laquintana,

Journal of Experimental & Clinical Cancer Research

2020

72

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

Patrizia Vici, Laura Pizzuti, Andrea Michelotti,

Oncotarget

2017

68

Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series

Anna Crispo, Maddalena Barba, Giuseppe D’Aiuto,

BMC Cancer

2013

62

p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation

Laura Damiano, P Di Stefano, Maria Pilar Camacho Leal,

Oncogene

2010

54

Neoadjuvant chemotherapy in triple‐negative breast cancer: A multicentric retrospective observational study in real‐life setting

Teresa Gamucci, Laura Pizzuti, Isabella Sperduti,

Journal of Cellular Physiology

2017

51

Page 1